The company has recommended the dividend of Rs 5 per share. EBDIT margin rose 25%.
Total income form operations for the Q4 came in at Rs 610.20 cores as against Rs 470. 85 crores reported in the corresponding period of the previous year. The company's head count stood more than 6200 employees.
Chairman and Managing Director of Biocon, Kiran Mazumdar Shaw said, "I am pleased with the overall performance that we have delivered in FY 12. Group sales have risen by 16% and PAT was sustained at previous levels despite lower net licensing income. We have delivered particularly strong growth in our Reserach Services and branded formulations business verticals.
Our balance sheet remains robust and our cash position is strong. the global economic outlook remains uncertain. However, we are confident that we will make significant progress across all our businesses."
Shares of the company on Friday were senn trading at Rs 237.45 up 3.26% on BSE at 10.45 am IST.